In a report released today, Brendan Smith from TD Cowen maintained a Hold rating on Novavax (NVAX – Research Report), with a price target ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN) ...

Kathryn Lowell and Tina Self were both chosen as Most Influential Women in the Bay Area this year by the Business Times. Now ...

The company now expects $650 million to $700 million in revenue for the year, down from previous guidance of $700 million to ...

A Trinity Life Sciences report found that more pharma product launches were successful in 2023 than the year before. Here are ...

The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...

The company has also pursued strategic partnerships, securing a $1.2bn licensing agreement with Sanofi in May 2024 to ...

Climate change and mosquitos are creating an epidemic of dengue in Oaxaca, as researchers work to counteract the disease.

Please turn to Slide 3. This presentation also includes references to a non-GAAP financial measure, which is forward-looking information for combined R&D and SG&A expense as adjusted for expense ...

U.S. FDA removes clinical hold on Investigational New Drug application for COVID-19-Influenza Combination and stand-alone influenza vaccine candidates Achieved total ...